Nuclear Radiology: Page 42

EANM opens ESMIT 2017 registration
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) has opened registration for its European School of Multimodality Imaging and Therapy (ESMIT) Spring School 2017, to be held 31 March to 2 April in Groningen, the Netherlands.
November 3, 2016
Nuclear medicine/radiopharma market primed for growth
By AuntMinnieEurope.com staff writers
The global nuclear medicine and radiopharmaceuticals market generated $4.7 billion U.S. (4.3 billion euros) in revenues in 2016 and is expected to grow at a compound annual growth rate of 9.3% to reach $7.3 billion (6.7 billion euros) by 2021, according to a new report from MarketsandMarkets.
October 25, 2016
Blue Earth PET radiotracer IDs prostate cancer recurrence
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Blue Earth Diagnostics is highlighting results from a phase III clinical trial of its Axumin (fluciclovine F-18) PET radiopharmaceutical agent indicating a 68% detection rate for prostate cancer recurrence.
October 23, 2016
CMR Naviscan highlights PEM study
By AuntMinnieEurope.com staff writers
PET developer Compañía Mexicana de Radiología (CMR) Naviscan is highlighting clinical results regarding positron emission mammography (PEM) published September 2 in European Radiology.
October 20, 2016
Philips collaborates with FluoroPharma for CardioPET study
By AuntMinnieEurope.com staff writers
Philips Healthcare said it has collaborated with radiopharmaceutical developer FluoroPharma Medical on a phase II clinical trial for FluoroPharma's CardioPET radiopharmaceutical.
October 18, 2016
MILabs launches micron-resolution SPECT at EANM
By AuntMinnieEurope.com staff writers
Preclinical imaging developer MILabs has launched a new micron-resolution SPECT unit for tissue samples at the European Association of Nuclear Medicine (EANM) congress in Barcelona, Spain.
October 16, 2016
Kromek announces new contracts worth 2.7M euros
By AuntMinnieEurope.com staff writers
Radiation detection technology firm Kromek has received new contracts worth more than 2.7 million euros, including agreements with the U.S. Defense Threat Reduction Agency and the U.K. Ministry of Defense.
October 16, 2016
AIPES: Mo-99 supply sufficient through 2017
By AuntMinnieEurope.com staff writers
The supply of molybdenum-99 (Mo-99) will sufficient through 2017, according to a new analysis from the Association of Imaging Producers & Equipment Suppliers (AIPES).
October 13, 2016
Sirtex cancer treatment added to ESMO guidelines
By AuntMinnieEurope.com staff writers
Cancer treatment firm Sirtex Medical said the European Society of Medical Oncology (ESMO) has included the company's yttrium-90 (Y-90) microspheres as an option in new guidelines for the treatment of intrahepatic cholangiocarcinoma (iCCA).
October 11, 2016
Maniawski: We must sell molecular imaging better
By Leo Cendrowicz
Molecular imaging can drive personalized medicine and revolutionize healthcare, but unless the nuclear medicine sector improves its communications and outreach, it could be years before we see the benefits, Piotr Maniawski of Philips Healthcare told a symposium in Brussels on Wednesday.
September 29, 2016
2016 09 30 08 44 10 655 Piotr Maniawski 20160930154506
Navidea gets $1M for 2 Lymphoseek milestones
By AuntMinnieEurope.com staff writers
Navidea Biopharmaceuticals will receive payments totaling $1 million for fulfilling two commercial milestones for its Lymphoseek radiopharmaceutical.
September 21, 2016
UAE steps up campaign on dose awareness
By Frances Rylands-Monk
Moves to limit medical radiation exposure are intensifying in the United Arab Emirates (UAE), and safety issues and education now are high on the agenda of healthcare professionals. Every effort must be made to reduce exposure and boost risk awareness, according to key participants at next month's summit in the region.
September 21, 2016
2016 09 13 12 27 01 419 Uae Flag 400
Previous Page
Page 42 of 90
Next Page